KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $77.9 billion.

  • Amgen's Total Non-Current Liabilities fell 390.99% to $77.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $77.9 billion, marking a year-over-year decrease of 390.99%. This contributed to the annual value of $83.6 billion for FY2024, which is 304.84% down from last year.
  • According to the latest figures from Q3 2025, Amgen's Total Non-Current Liabilities is $77.9 billion, which was down 390.99% from $78.0 billion recorded in Q2 2025.
  • Over the past 5 years, Amgen's Total Non-Current Liabilities peaked at $86.2 billion during Q4 2023, and registered a low of $45.1 billion during Q2 2021.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $77.9 billion (2025), whereas its average is $68.0 billion.
  • Per our database at Business Quant, Amgen's Total Non-Current Liabilities soared by 5482.47% in 2023 and then crashed by 564.16% in 2025.
  • Amgen's Total Non-Current Liabilities (Quarter) stood at $47.9 billion in 2021, then grew by 16.36% to $55.7 billion in 2022, then surged by 54.82% to $86.2 billion in 2023, then decreased by 3.05% to $83.6 billion in 2024, then fell by 6.83% to $77.9 billion in 2025.
  • Its last three reported values are $77.9 billion in Q3 2025, $78.0 billion for Q2 2025, and $80.7 billion during Q1 2025.